{"FsPickler":"0.9.6","type":"System.String","value":"@article{Wieman_1998,\n\tdoi = {10.2337/diacare.21.5.822},\n\turl = {http://dx.doi.org/10.2337/diacare.21.5.822},\n\tyear = 1998,\n\tmonth = {may},\n\tpublisher = {American Diabetes Association},\n\tvolume = {21},\n\tnumber = {5},\n\tpages = {822--827},\n\tauthor = {T. J. Wieman and J. M. Smiell and Y. Su},\n\ttitle = {Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-$\\lbrace$BB$\\rbrace$ (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase $\\lbrace$III$\\rbrace$ randomized placebo-controlled double-blind study},\n\tjournal = {Diabetes Care}\n}"}